Conotoxins: Review and Docking Studies to determine potentials of Conotoxin as an Anticancer Drug Molecule

Publisher： Bentham Science Publishers

E-ISSN： 1873-4294|12|8|845-851

ISSN： 1568-0266

Source： Current Topics in Medicinal Chemistry, Vol.12, Iss.8, 2012-04, pp. : 845-851

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Docking and Virtual Screening to Identify PKC Agonists: Potentials in Anticancer Therapeutics

By  

Current Computer - Aided Drug Design, Vol. 10, Iss. 1, 2014-03 ,pp. : 50-58

Bentham Science Publishers

Access to resources Recommend Favorite

SAR, QSAR and Docking of Anticancer Flavonoids and Variants: A Review

By  

Current Topics in Medicinal Chemistry, Vol. 12, Iss. 24, 2012-01 ,pp. : 2785-2809

Bentham Science Publishers

Access to resources Recommend Favorite

RITA - a small-molecule anticancer drug that targets p53

By Doggrell Sheila A  

Expert Opinion on Investigational Drugs, Vol. 14, Iss. 6, 2005-06 ,pp. : 739-742

Informa Healthcare

Access to resources Recommend Favorite

Structure-Activity Studies on Alpha-Conotoxins

By  

Current Pharmaceutical Design, Vol. 17, Iss. 38, 2011-12 ,pp. : 4226-4241

Bentham Science Publishers

Access to resources Recommend Favorite

Synthesis, Anticancer Screening and Molecular Docking Studies of New Heterocycles with Trimethoxyphenyl Scaffold as Combretastatin Analogues

By  

Mini Reviews in Medicinal Chemistry, Vol. 18, Iss. 8, 2018-04 ,pp. : 717-727

Bentham Science Publishers

Access to resources Recommend Favorite